Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1960 1
1963 1
1964 2
1966 1
1969 2
1970 1
1971 2
1972 1
1973 2
1975 2
1976 3
1977 3
1978 6
1979 4
1980 2
1981 4
1982 6
1983 3
1984 9
1985 9
1986 10
1987 6
1988 16
1989 10
1990 18
1991 14
1992 18
1993 14
1994 13
1995 17
1996 21
1997 27
1998 18
1999 22
2000 35
2001 42
2002 34
2003 42
2004 48
2005 58
2006 54
2007 84
2008 90
2009 70
2010 76
2011 77
2012 99
2013 102
2014 114
2015 127
2016 156
2017 159
2018 153
2019 180
2020 258
2021 305
2022 318
2023 308
2024 297
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,230 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for severe ld
Search for Séverine LD instead (3 results)
Severe Legionnaires' disease.
Rello J, Allam C, Ruiz-Spinelli A, Jarraud S. Rello J, et al. Ann Intensive Care. 2024 Apr 2;14(1):51. doi: 10.1186/s13613-024-01252-y. Ann Intensive Care. 2024. PMID: 38565811 Free PMC article. Review.
Mortality in ICU patients, immunocompromised patients or patients with a nosocomial source of LD can reach 40% despite appropriate antimicrobial therapy. Regarding pathogenesis, no Legionella-specific virulence factors have been associated with severity; however, re …
Mortality in ICU patients, immunocompromised patients or patients with a nosocomial source of LD can reach 40% despite appropriate an …
Secukinumab demonstrates high efficacy and a favourable safety profile in paediatric patients with severe chronic plaque psoriasis: 52-week results from a Phase 3 double-blind randomized, controlled trial.
Bodemer C, Kaszuba A, Kingo K, Tsianakas A, Morita A, Rivas E, Papanastasiou P, Keefe D, Patekar M, Charef P, Zhang L, Cafoncelli S, Papavassilis C. Bodemer C, et al. J Eur Acad Dermatol Venereol. 2021 Apr;35(4):938-947. doi: 10.1111/jdv.17002. Epub 2021 Jan 19. J Eur Acad Dermatol Venereol. 2021. PMID: 33068444 Free PMC article. Clinical Trial.
OBJECTIVES: Here, the efficacy and safety of two secukinumab dosing regimens [low dose (LD) and high dose (HD)] in paediatric patients with severe chronic plaque psoriasis over one year are reported. ...The efficacy of both doses was sustained to Week 52 with secuki …
OBJECTIVES: Here, the efficacy and safety of two secukinumab dosing regimens [low dose (LD) and high dose (HD)] in paediatric patient …
Efficacy and Safety of Lebrikizumab, a High-Affinity Interleukin 13 Inhibitor, in Adults With Moderate to Severe Atopic Dermatitis: A Phase 2b Randomized Clinical Trial.
Guttman-Yassky E, Blauvelt A, Eichenfield LF, Paller AS, Armstrong AW, Drew J, Gopalan R, Simpson EL. Guttman-Yassky E, et al. JAMA Dermatol. 2020 Apr 1;156(4):411-420. doi: 10.1001/jamadermatol.2020.0079. JAMA Dermatol. 2020. PMID: 32101256 Free PMC article. Clinical Trial.
Participants were adults 18 years or older with moderate to severe AD. INTERVENTIONS: Patients were randomized 2:3:3:3 to placebo every 2 weeks or to subcutaneous injections of lebrikizumab at the following doses: 125 mg every 4 weeks (250-mg loading dose [LD]), 250 …
Participants were adults 18 years or older with moderate to severe AD. INTERVENTIONS: Patients were randomized 2:3:3:3 to placebo eve …
Lipodystrophy: Syndrome of severe insulin resistance.
Bindlish S, Presswala LS, Schwartz F. Bindlish S, et al. Postgrad Med. 2015 Jun;127(5):511-6. doi: 10.1080/00325481.2015.1015927. Epub 2015 Feb 17. Postgrad Med. 2015. PMID: 25690482 Review.
CONTEXT: Lipodystrophy (LD) is a relatively rare complex collection of diseases that can be congenital or acquired. ...The search terms were lipodystrophy, congenital LD, acquired LD, HIV-associated LD, severe insulin resistance, adiposity, obes …
CONTEXT: Lipodystrophy (LD) is a relatively rare complex collection of diseases that can be congenital or acquired. ...The search ter …
Hyper-inflammatory profile and immunoparalysis in patients with severe Legionnaires' disease.
Allam C, Mouton W, Testaert H, Ginevra C, Fessy N, Ibranosyan M, Descours G, Beraud L, Guillemot J, Chapalain A, Albert-Vega C, Richard JC, Argaud L, Friggeri A, Labeye V, Jamilloux Y, Freymond N, Venet F, Lina G, Doublet P, Ader F, Trouillet-Assant S, Jarraud S. Allam C, et al. Front Cell Infect Microbiol. 2023 Oct 27;13:1252515. doi: 10.3389/fcimb.2023.1252515. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 37965258 Free PMC article.
INTRODUCTION: Severe Legionnaires' disease (LD) can lead to multi-organ failure or death in 10%-30% of patients. Although hyper-inflammation and immunoparalysis are well described in sepsis and are associated with high disease severity, little is known about …
INTRODUCTION: Severe Legionnaires' disease (LD) can lead to multi-organ failure or death in 10%-30% of patients. Although hype …
Learning disabilities.
Lyon GR. Lyon GR. Future Child. 1996 Spring;6(1):54-76. Future Child. 1996. PMID: 8689262 Review.
The "real" prevalence of LD is subject to much dispute because of the lack of an agreed-upon definition of LD with objective identification criteria. ...Children with severe learning disabilities are likely to manifest an increased number of and increased …
The "real" prevalence of LD is subject to much dispute because of the lack of an agreed-upon definition of LD with objective i …
Immunomodulation Through Low-Dose Radiation for Severe COVID-19: Lessons From the Past and New Developments.
Hanekamp YN, Giordano J, Hanekamp JC, Khan MK, Limper M, Venema CS, Vergunst SD, Verhoeff JJC, Calabrese EJ. Hanekamp YN, et al. Dose Response. 2020 Sep 22;18(3):1559325820956800. doi: 10.1177/1559325820956800. eCollection 2020 Jul-Sep. Dose Response. 2020. PMID: 33013251 Free PMC article. Review.
The ongoing COVID-19 pandemic has elicited renewed scientific interest in LD-RT and multiple small clinical trials have recently corroborated the historical LD-RT findings and demonstrated preliminary efficacy and immunomodulation for the treatment of severe …
The ongoing COVID-19 pandemic has elicited renewed scientific interest in LD-RT and multiple small clinical trials have recently corr …
Exercise regulation of hepatic lipid droplet metabolism.
Pino-de la Fuente F, Bórquez JC, Díaz-Castro F, Espinosa A, Chiong M, Troncoso R. Pino-de la Fuente F, et al. Life Sci. 2022 Jun 1;298:120522. doi: 10.1016/j.lfs.2022.120522. Epub 2022 Mar 30. Life Sci. 2022. PMID: 35367244 Review.
The imbalance of LD function causes non-alcoholic fatty liver disease (NAFLD). Studies show that exercise attenuates NAFLD by decreasing LD content; however, reports show metabolic benefits without changes in LD amount (intrahepatic triglyceride levels) in NA …
The imbalance of LD function causes non-alcoholic fatty liver disease (NAFLD). Studies show that exercise attenuates NAFLD by decreas …
Urinary Kidney Injury Biomarkers Are Associated with Ischemia-Reperfusion Injury Severity in Kidney Allograft Recipients.
van Duijl TT, de Rooij ENM, Treep MM, Koelemaij ME, Romijn FPHTM, Hoogeveen EK, Ruhaak LR, le Cessie S, de Fijter JW, Cobbaert CM. van Duijl TT, et al. Clin Chem. 2023 Aug 2;69(8):924-935. doi: 10.1093/clinchem/hvad086. Clin Chem. 2023. PMID: 37477911
METHODS: Urine samples from kidney allograft recipients with mild (LD; n = 199) or severe (DCD; n = 71) ischemia-reperfusion injury (IRI) were analyzed for neutrophil gelatinase-associated lipocalin (NGAL), insulin-like growth factor-binding protein 7 (IGFBP7), tiss …
METHODS: Urine samples from kidney allograft recipients with mild (LD; n = 199) or severe (DCD; n = 71) ischemia-reperfusion i …
Lafora disease: severe phenotype associated with homozygous deletion of the NHLRC1 gene.
Kecmanović M, Jović N, Cukić M, Keckarević-Marković M, Keckarević D, Stevanović G, Romac S. Kecmanović M, et al. J Neurol Sci. 2013 Feb 15;325(1-2):170-3. doi: 10.1016/j.jns.2012.12.006. Epub 2013 Jan 11. J Neurol Sci. 2013. PMID: 23317923 Review.
Lafora disease (LD) is a severe, autosomal recessive, latechildhood- to teenage-onset, progressive myoclonic epilepsy. ...Besides, it widens the spectrum of LD patients with severe phenotype and NHLRC1 mutations....
Lafora disease (LD) is a severe, autosomal recessive, latechildhood- to teenage-onset, progressive myoclonic epilepsy. ...Besi …
3,230 results